日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Vaping and cancer metastasis: novel preclinical insights and results from the All of Us Research Program

电子烟与癌症转移:来自“我们所有人”研究计划的全新临床前见解和结果

Pillai, Dhruv G; Chau, Cindy H; Price, Douglas K; Figg, William D

Direct Co-Targeting of Bcl-xL and Mcl-1 Exhibits Synergistic Effects in AR-V7-Expressing CRPC Models.

Bcl-xL 和 Mcl-1 的直接共同靶向在 AR-V7 表达的 CRPC 模型中表现出协同效应

Brim Benjamin C, Leon Andres F, Beatson Erica L, Kindrick Jessica D, Bhadresha Kinjal, Zhang Xiaohu, Napoli Giulia C, Risdon Emily N, Schmidt Keith T, Wilson Kelli M, McKnight Crystal, Beck Erin, Klumpp-Thomas Carleen, Ceribelli Michele, Yin JuanJuan, Sowalsky Adam G, Price Douglas K, Chau Cindy H, Thomas Craig J, Figg William D

Bridging Health Disparities: a Genomics and Transcriptomics Analysis by Race in Prostate Cancer

弥合健康差异:前列腺癌种族基因组学和转录组学分析

Lee, Kristi Y; Beatson, Erica L; Steinberg, Seth M; Chau, Cindy H; Price, Douglas K; Figg, William D

Targeting the metastatic niche: Single-cell lineage tracing in prime time

靶向转移微环境:单细胞谱系追踪正值黄金时期

Sommer, Elijah R; Napoli, Giulia C; Chau, Cindy H; Price, Douglas K; Figg, William D

GNRH2 Polymorphism in Men With Prostate Cancer Treated With Androgen Deprivation Therapy

接受雄激素剥夺疗法治疗的前列腺癌患者的GNRH2多态性

Sissung, Tristan M; Lochrin, Sarah; Liu, Tyler; Schmidt, Keith; Strope, Jonathan; Risdon, Emily; Choo-Wosoba, Hyoyoung; Venzon, David J; Lassoued, Wiem; Sater, Houssein A; Walter-Rodriguez, Beatriz; Price, Douglas K; Figg, William D

Drugging the undruggable: activity-based protein profiling offers opportunities for targeting the KLK activome

攻克难成药靶点:基于活性的蛋白质谱分析为靶向KLK激活组提供了契机

Lee, Kristi Y; Chau, Cindy H; Price, Douglas K; Figg, William D

Serum markers, obesity and prostate cancer risk: results from the prostate cancer prevention trial

血清标志物、肥胖与前列腺癌风险:前列腺癌预防试验的结果

Chau, Cindy H; Till, Cathee; Price, Douglas K; Goodman, Phyllis J; Neuhouser, Marian L; Pollak, Michael N; Thompson, Ian M; Figg, William D

Examining HSD3B1 as a possible biomarker to detect prostate cancer patients who are likely to progress on ADT

研究HSD3B1作为潜在生物标志物,用于识别可能在ADT治疗后出现疾病进展的前列腺癌患者。

Handy, Whitney F; Schmidt, Keith T; Price, Douglas K; Figg, William D

Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population

在种族多元化的患者群体中,生殖系BRCA2突变频率的增加与前列腺癌转移相关。

Petrovics, Gyorgy; Price, Douglas K; Lou, Hong; Chen, Yongmei; Garland, Lisa; Bass, Sara; Jones, Kristine; Kohaar, Indu; Ali, Amina; Ravindranath, Lakshmi; Young, Denise; Cullen, Jennifer; Dorsey, Tiffany H; Sesterhenn, Isabell A; Brassell, Stephen A; Rosner, Inger L; Ross, Doug; Dahut, William; Ambs, Stefan; Figg, William Douglas; Srivastava, Shiv; Dean, Michael

Molecular drivers of metastatic castrate-resistant prostate cancer: New roads to resistance

转移性去势抵抗性前列腺癌的分子驱动因素:耐药性的新途径

Huang, Phoebe A; Price, Douglas K; Figg, William D